Coloplast A/S (VIE:COLO)

Market Cap	14.44B -23.3%
Revenue (ttm)	3.80B +2.1%
Net Income	369.57M -32.2%
EPS	1.64 -32.2%
Shares Out	n/a
PE Ratio	39.06
Forward PE	18.53
Dividend	3.08 (4.90%)
Ex-Dividend Date	May 18, 2026

Volume	n/a
Open	63.48
Previous Close	64.26
Day's Range	63.40 - 63.64
52-Week Range	49.54 - 85.46
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 18, 2026

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories ...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1954
• Employees: 17,213
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: COLO

Financial Performance

In fiscal year 2025, Coloplast's revenue was 27.87 billion, an increase of 3.12% compared to the previous year's 27.03 billion. Earnings were 3.64 billion, a decrease of -28.03%.

Financial numbers in DKK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 3, 2026

Data Sources Report a data error